Skip to content

Efficacy of intraoperatory optimisation of fluids guided with transoesophageal doppler monitorisation

Efficacy of intraoperatory optimisation of fluids guided with transoesophageal doppler monitorisation: a multicentre randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN93543537
Enrollment
840
Registered
2011-02-17
Start date
2011-01-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High risk surgical procedures under general anaesthesia Surgery General anaesthesia

Interventions

Intervention group: transoesophageal doppler monitorisation Control group: conventional monitorisation The intervention group consists of cardiovascular continuous oes

Sponsors

Deltex Medical Ltd (Spain)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient is under general anaesthesia 2. Major surgery with more than 2 hours 3. Estimated volume loss superior to 15% of volemia 4. Procedure with estimated transfusion need of 2 units of blood substitute 5. High risk surgical procedures in urology, gynaecology, abdominal surgery and traumalogy 6. Aged 18 years or over, either sex

Exclusion criteria

Exclusion criteria: 1. Patient aged less than 18 years 2. High risk surgical procedures with unforeseen complications 3. Severe bleeding 4. Nasal or facial trauma 5. Trauma preventing proper insertion of the product (probe) 6. Oesophageal anomalies such as stenosis, oesophageal varices with risk of rupture, severe oesophagitis 7. Oesophageal stents 8. Oesophageal tumour 9. Surgery at the level of the oesophagus or upper airway 10. Pneumo a/o cardiopathy that needs treatment before surgery 11. American Society of Anaesthesiology (ASA) grade IV - V

Design outcomes

Primary

MeasureTime frame
Post-operative short term complications

Secondary

MeasureTime frame
Measured all along the hospital stay: 1. Hospital length of stay 2. Morbidity and mortality, also measured at the sixth month after hospital discharge

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026